Ann E. Kingsbury

4.7k total citations · 2 hit papers
50 papers, 3.9k citations indexed

About

Ann E. Kingsbury is a scholar working on Cellular and Molecular Neuroscience, Neurology and Molecular Biology. According to data from OpenAlex, Ann E. Kingsbury has authored 50 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 29 papers in Neurology and 8 papers in Molecular Biology. Recurrent topics in Ann E. Kingsbury's work include Parkinson's Disease Mechanisms and Treatments (27 papers), Neurological disorders and treatments (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). Ann E. Kingsbury is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (27 papers), Neurological disorders and treatments (17 papers) and Neuroscience and Neuropharmacology Research (15 papers). Ann E. Kingsbury collaborates with scholars based in United Kingdom, United States and Australia. Ann E. Kingsbury's co-authors include R. Balázs, Vittorio Gallo, Andrew J. Lees, Oliver Foster, Angus Nisbet, David J. Eve, Rina Bandopadhyay, O Föster, Rebecca Lever and Peter S. Whitton and has published in prestigious journals such as Journal of Neuroscience, Neurology and Annals of Neurology.

In The Last Decade

Ann E. Kingsbury

49 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The role of depolarization in the survival and differentiation of cerebellar granule cells in culture

1987 695 citations Vittorio Gallo, Ann E. Kingsbury et al. profile →
Kinase activity is required for the toxic effects of mutant LRRK2/dardarin

2006 591 citations Elisa Greggio, Shushant Jain et al. Neurobiology of Disease profile →

Peers

Countries citing papers authored by Ann E. Kingsbury

Since Specialization

Citations

This map shows the geographic impact of Ann E. Kingsbury's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Kingsbury with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Kingsbury more than expected).

Fields of papers citing papers by Ann E. Kingsbury

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Kingsbury. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Kingsbury. The network helps show where Ann E. Kingsbury may publish in the future.

Co-authorship network of co-authors of Ann E. Kingsbury

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Kingsbury. A scholar is included among the top collaborators of Ann E. Kingsbury based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Kingsbury. Ann E. Kingsbury is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model 2010 ·Movement Disorders ·Ann E. Kingsbury, Rina Bandopadhyay, Laura Silveira‐Moriyama, Hilary Ayling, Constantinos Kallis, William Sterlacci, (unknown), Werner Poewe, Andrew J. Lees	113
2	Hyposmia in progressive supranuclear palsy 2010 ·Movement Disorders ·Laura Silveira‐Moriyama, Graham R.V. Hughes, Alistair Church, Hilary Ayling, David R. Williams, Aviva Petrie, Janice L. Holton, Tamás Révész, Ann E. Kingsbury, Huw R. Morris, David J. Burn, Andrew J. Lees	42
3	The CRF-like peptide urocortin produces a long-lasting recovery in rats made hemiparkinsonian by 6-hydroxydopamine or lipopolysaccharide 2008 ·Journal of the Neurological Sciences ·Amjad Abuirmeileh, Alexander Harkavyi, Ann E. Kingsbury, Rebecca Lever, Peter S. Whitton	10
4	The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF1 receptors 2008 ·European Journal of Pharmacology ·Amjad Abuirmeileh, Alexander Harkavyi, Ann E. Kingsbury, Rebecca Lever, Peter S. Whitton	11
5	DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders 2007 ·Neurobiology of Disease ·Ravindran Kumaran, Ann E. Kingsbury, Ian Coulter, Tammaryn Lashley, David R. Williams, Rohan de Silva, David Mann, Tamás Révész, (unknown), Rina Bandopadhyay	29
6	The corticotrophin‐releasing factor‐like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease 2007 ·European Journal of Neuroscience ·Amjad Abuirmeileh, Rebecca Lever, Ann E. Kingsbury, Andrew J. Lees, Ian C. Locke, Richard A. Knight, Hardial S. Chowdrey, Christopher S. Biggs, Peter S. Whitton	33
7	Kinase activity is required for the toxic effects of mutant LRRK2/dardarin breakdown → 2006 ·Neurobiology of Disease ·Elisa Greggio, Shushant Jain, Ann E. Kingsbury, Rina Bandopadhyay, Patrick A. Lewis, Alice Kaganovich, Marcel P. van der Brug, Alexandra Beilina, Jeff Blackinton, Kelly Jean Thomas Craig, Rili Ahmad, David W. Miller, Sashi Kesavapany, Andrew Singleton, Andrew J. Lees, Victoria L. Harvey, Kirsten Harvey, Mark Cookson	591
8	Striatal dopaminergic neurons are lost with Parkinson's disease progression 2006 ·Movement Disorders ·Michelle J. Porritt, Ann E. Kingsbury, Andrew Hughes, David W. Howells	18
9	Synphilin-1 and parkin show overlapping expression patterns in human brain and form aggresomes in response to proteasomal inhibition 2005 ·Neurobiology of Disease ·Rina Bandopadhyay, Ann E. Kingsbury, Miratul M. K. Muqit, Kirsten Harvey, (unknown), Linda Kilford, Simone Engelender, Michael G. Schlossmacher, Nicholas Wood, David S. Latchman, Victoria L. Harvey, Andrew J. Lees	34
10	Alteration in α‐synuclein mRNA expression in Parkinson's disease 2003 ·Movement Disorders ·Ann E. Kingsbury, Susan E. Daniel, (unknown), Sarah Eisen, Andrew J. Lees, Oliver Foster	84
11	Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson’s disease 2003 ·Neurochemistry International ·Gary E. Gibson, Ann E. Kingsbury, Hui Xu, J. Gordon Lindsay, Daniel Sánchez‐Zuriaga, O Föster, A. J. Lees, John P. Blass	91
12	Metabolic enzyme expression in dopaminergic neurons in Parkinson's disease: An in situ hybridization study 2001 ·Annals of Neurology ·Ann E. Kingsbury, Jonathan M. Cooper, Anthony H.V. Schapira, Oliver Foster	16
13	The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: An in situ hybridization study 1999 ·Movement Disorders ·Ann E. Kingsbury, C. David Marsden, Oliver Foster	1
14	NMDA NR1 subunit mRNA and glutamate NMDA-sensitive binding are differentially affected in the striatum and pre-frontal cortex of Parkinson’s disease patients 1999 ·Neuropharmacology ·(unknown), Bernd Bunnemann, Ann E. Kingsbury, David G. Trist, Norman G. Bowery	21
15	The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: Anin situ hybridization study 1999 ·Movement Disorders ·Ann E. Kingsbury, C. D. Marsden, Oliver Foster	23
16	DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect? 1998 ·Movement Disorders ·Ann E. Kingsbury, (unknown), Oliver Foster	76
17	Dopamine transporter (DAT) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson's disease 1996 ·Molecular Brain Research ·Kathleen A. Harrington, S.J. Augood, Ann E. Kingsbury, O Föster, P.C. Emson	79
18	Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease 1995 ·Neuroscience ·Angus Nisbet, O Föster, Ann E. Kingsbury, David J. Eve, S. E. Daniel, C. D. Marsden, Andrew J. Lees	94
19	Tissue pH as an indicator of mRNA preservation in human post-mortem brain 1995 ·Molecular Brain Research ·Ann E. Kingsbury, Oliver Foster, Angus Nisbet, Nigel J. Cairns, (unknown), David J. Eve, Andrew J. Lees, C. David Marsden	295
20	Effect of depolarization on the maturation of cerebellar granule cells in culture 1988 ·Developmental Brain Research ·R. Balázs, Vittorio Gallo, Ann E. Kingsbury	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact